医疗团体敦促CMS解决欺诈,人工智能监督和Medicare Advantage政策问题. Healthcare groups urge CMS to address fraud, AI oversight, and Medicare Advantage policies.

包括Inadev公司,美国神经学会和加利福尼亚州蓝盾在内的医疗机构于2026年4月10日向CMS提交了公开意见,涉及欺诈检测,人工智能监督以及提出的2027年Medicare Advantage支付政策. Healthcare organizations including Inadev Corp., the American Academy of Neurology, and Blue Shield of California submitted public comments to CMS on April 10, 2026, addressing fraud detection, artificial intelligence oversight, and proposed 2027 Medicare Advantage payment policies. 其他组织如美国关怀和美国医疗团体协会呼吁提高透明度,减少监管负担. Other groups like U.S. Renal Care and the American Medical Group Association called for improved transparency and reduced regulatory burdens.